USD 6.16 billion
Biochips Market Size, Share, Growth Analysis, By Type (DNA Chips, Lab-On-A-Chip), By Fabrication Technology (Microarrays, Microfluidics), By Application (Genomics, Drug Development), By End User, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG45A2235 |
Region:
Global |
Published Date: November, 2024
Pages:
157
|Tables:
90
|Figures:
76
Biochip Market Insights
Biochip Market size was valued at USD 10.74 Billion in 2023 and is poised to grow from USD 12.1 Billion in 2024 to USD 31.45 Billion by 2032, growing at a CAGR of 12.68% during the forecast period (2025-2032).
The lab-on-a-chip and microarrays (biochips) market experienced significant impacts from the COVID-19 pandemic. The pandemic heightened the demand for these technologies, as they were used for diagnostics, epidemiological studies, and antibody response research related to COVID-19.
Moving forward, the market is projected to grow further due to the increasing need for point-of-care testing, the rising incidence of chronic diseases, and the expanding use of proteomics and genomics in cancer research.
The growth drivers of the market include the emphasis on developing advanced diagnostic tests by major players, the prevalence of chronic diseases worldwide, and the adoption of biochips in proteomics research.
Chronic diseases are a leading cause of disability and mortality, especially among the elderly population. This has prompted research and development of new lab-on-a-chip-based systems for diagnosing chronic illnesses, creating opportunities for market expansion.
Biochips are gaining popularity in biomedical and biotechnological research, particularly in proteomics. The advantages of these biochips include low sample consumption and their effectiveness in proteome-wide analysis, essential for biomarker and drug discoveries. Approvals for innovative products, like the patented COVID-19 diagnostic assay, have also contributed to the market's growth.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
dna chip
Fastest Growth
dna chip
Growth Rate
15.2% CAGR
Global Biochip Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Biochip Market Segmental Analysis
Global Biochips Market is segmented by Type, Fabrication Technology, Application, End User, and Region. Based on Type, the market is segmented into DNA Chips (Gene Expression, SNP Genotyping, Cancer Diagnosis & Treatment, Genomics, Drug Discovery, Agricultural Biotechnology, Other DNA Chip Applications), Lab-On-A-Chip (Clinical Diagnostics, Genomics, IVD & POC, Proteomics, Drug Discovery, Other Loac Applications), Protein Chips (Proteomics, Expression Profiling, Diagnostics, High-Throughput Screening, Drug Discovery, Other Protein Chip Applications), Other Arrays (Cell Arrays, Tissue Arrays). Based on Fabrication Technology, the market is segmented into Microarrays, Microfluidics. Based on Application, the market is segmented into Genomics, Drug Development, Agriculture, and Others. Based on End User, the market is segmented into Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Analysis By Product
The largest segment, DNA chips, has revolutionized genetic research and diagnostics, boasting the ability to analyze thousands of genes simultaneously, unraveling the intricacies of our genetic makeup. Its swift and accurate analysis capabilities have made it an invaluable tool across various applications, from disease diagnosis to personalized medicine. With the surging demand for precision medicine and personalized healthcare solutions, DNA chips are the epitome of cutting-edge innovation, unraveling the secrets hidden within our genes and paving the way for tailored medical interventions.
Simultaneously, the fastest-growing segment, Lab-on-a-chip, is a beacon of progress in the biochip industry. The demand for point-of-care testing and decentralized diagnostics has catapulted this segment's growth, enabling healthcare professionals to swiftly conduct tests and deliver results at the patient's bedside or in remote regions. The transformative potential of Lab-on-a-chip technology extends beyond traditional healthcare settings, offering cost-effective and efficient diagnostic solutions to resource-limited regions. With its remarkable strides in making healthcare more accessible and efficient, Lab-on-a-chip is a trailblazer in the biochip realm.
Analysis By Fabrication Technology
The largest segment, microarrays, stands as a testament to the power of high-throughput analysis and its versatility across various applications. Microarrays, also known as DNA chips, have revolutionized genetic research and diagnostics, enabling researchers to analyze thousands of genes simultaneously. This incredible capability has unlocked a wealth of information about our genetic makeup, paving the way for advancements in disease diagnosis, drug discovery, and personalized medicine. With such unparalleled capabilities, microarrays have solidified their position as the cornerstone of the biochip industry, driving transformative research and tailored medical interventions.
Concurrently, the fastest-growing segment, microfluidics, embodies innovation at its finest. Through the integration of fluid dynamics on a microscale, microfluidics has redefined laboratory processes, accelerating analysis and bringing forth a new era of precision diagnostics. This revolutionary technology is witnessing rapid adoption due to its ability to minimize sample and reagent consumption while expediting results, making it an ideal choice for point-of-care testing and decentralized diagnostics. As the demand for efficient and accessible healthcare solutions continues to soar, microfluidics has emerged as the beacon of progress, empowering healthcare professionals to swiftly conduct tests at the patient's bedside or in resource-limited regions. Its exceptional growth trajectory underscores its potential to reshape the biochip industry and elevate healthcare accessibility worldwide.
Global Biochip Market By type
To get detailed analysis on other segments, Request For Free Sample Report
Biochip Market Regional Insights
North America stands tall as the dominating region, fostering a fertile ground for biochip advancements and applications. With its cutting-edge research facilities, robust healthcare infrastructure, and a strong focus on precision medicine, North America commands the largest market share in the global biochip industry. The region's unwavering commitment to technological innovation and its thriving biotechnology and pharmaceutical sectors have catapulted it to the forefront of biochip development.
Simultaneously, the Asia-Pacific region is the fastest-growing segment in the global biochip landscape. With a rising focus on personalized medicine and an increasing demand for advanced diagnostics, countries like China, India, and Japan are witnessing a rapid surge in biochip adoption. The Asia-Pacific region's burgeoning market is further propelled by an upsurge in research and development activities, government initiatives supporting biotechnology advancements, and a growing emphasis on improving healthcare accessibility. As a result, the region is experiencing substantial growth and is projected to gain a significant market share in the foreseeable future.
Global Biochip Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Biochip Market Dynamics
Drivers
Increasing Demand For Personalized Medicine And Precision Diagnostics
- As advancements in genomics and proteomics provide insights into individual genetic profiles and disease mechanisms, there is a growing need for targeted and tailored medical interventions. Biochips play a crucial role in analyzing large datasets quickly and efficiently, facilitating the identification of specific genetic mutations and biomarkers associated with diseases. This trend towards personalized medicine is enhancing patient outcomes and driving the adoption of biochips in clinical settings.
Restraints
High Cost Of Development And Implementation
- Developing biochips with cutting-edge technologies and ensuring their accuracy and reliability can be a costly and time-consuming process. Additionally, integrating biochips into existing healthcare systems and laboratories may require substantial investments. The high initial investment and ongoing maintenance costs can pose challenges for some healthcare facilities and limit the widespread adoption of biochips. However, as technology advances and economies of scale are achieved, the cost barriers are expected to gradually diminish, allowing for broader market penetration.
Request Free Customization of this report to help us to meet your business objectives.
Biochip Market Competitive Landscape
The competitive landscape of the biochips market is comprehensively covered in the market report, offering detailed insights into key competitors. The provided data points focus on each company's specific involvement in the biochips market. These include company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites and capacities, as well as strengths and weaknesses. The report also highlights product launches, product width and breadth, and application dominance.
Top Player’s Company Profiles
- Abbott Laboratories
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Standard BioTools Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Roche Diagnostics
- Micronit Microtechnologies
- Randox Laboratories Ltd.
- RayBiotech, Inc.
- Invitae
- CapitalBio Corporation
- Genscript Biotech Corp
- Takara Bio Usa Holdings, Inc.
Recent Developments
- In March 2020, Agilent Technologies, a renowned global leader in life sciences, diagnostics, and applied chemical markets, made an exciting announcement unveiling the introduction of three cutting-edge microarrays. These state-of-the-art microarrays were specifically designed to cater to the ever-evolving needs of cytogenetic laboratories, enabling them to conduct groundbreaking research in both prenatal and postnatal studies.
Biochip Key Market Trends
- One key market trend in the biochips industry is the growing emphasis on personalized medicine and precision diagnostics. As advancements in genomics and proteomics continue to unfold, there is a rising demand for tailored medical interventions and treatments based on an individual's unique genetic makeup. Biochips, with their ability to analyze vast amounts of genetic data and protein interactions, are playing a pivotal role in this trend. The integration of biochips with other cutting-edge technologies, such as artificial intelligence and machine learning, is driving the development of sophisticated diagnostic tools and therapeutic solutions. By leveraging biochips' high-throughput capabilities and data analysis algorithms, healthcare professionals can identify specific genetic mutations and biomarkers associated with diseases more accurately and efficiently.
Biochip Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Deployment mode team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analyses, The biochips market is experiencing significant growth and innovation due to the increasing demand for personalized medicine and precision diagnostics. Advancements in genomics and proteomics have propelled the adoption of biochips, enabling researchers and healthcare professionals to analyze vast amounts of genetic and protein data simultaneously. The integration of biochips with artificial intelligence and machine learning is leading to the development of sophisticated diagnostic tools and targeted therapies. Additionally, the trend of decentralized diagnostics and point-of-care testing is gaining traction, enhancing accessibility to healthcare in resource-limited regions.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 9.53 billion |
| Market size value in 2031 | USD 27.91 billion |
| Growth Rate | 12.68% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Biochip Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Biochip Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Biochip Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Biochip Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Biochip Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Biochip Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
